Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
University of Pittsburgh
University of Pittsburgh
University of Kentucky
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Akeso
Intensity Therapeutics, Inc.
ETOP IBCSG Partners Foundation
Akeso
NYU Langone Health
Ludwig Institute for Cancer Research
Merck Sharp & Dohme LLC
Gritstone bio, Inc.
Gritstone bio, Inc.
Institut Claudius Regaud
Viralytics
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MedImmune LLC
Centre Hospitalier Universitaire de Saint Etienne
University Hospital Southampton NHS Foundation Trust